VLA 0.00% $1.75 viralytics limited

So if BMS are paying $4b to get 35% of Nektar's drug and Merck...

  1. 9,595 Posts.
    lightbulb Created with Sketch. 330
    So if BMS are paying $4b to get 35% of Nektar's drug and Merck are paying $450m to get all of vla's (this is Merck's offer less our cash).

    That means BMS are paying over 25 times what Merck are paying proportionally.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.